| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1045433471 |
| P356 | DOI | 10.1038/SJ.LEU.2404920 |
| P698 | PubMed publication ID | 17805333 |
| P5875 | ResearchGate publication ID | 6035817 |
| P50 | author | Jane L. Liesveld | Q60687367 |
| P2093 | author name string | Rowe JM | |
| Phillips GL | |||
| Blumberg N | |||
| Heal JM | |||
| P2860 | cites work | A randomized trial of washed red blood cell and platelet transfusions in adult acute leukemia [ISRCTN76536440] | Q24801336 |
| What would Karl Landsteiner do? The ABO blood group and stem cell transplantation | Q36207276 | ||
| Antibodies to plasma proteins: an association with platelet transfusion refractoriness | Q68059093 | ||
| The role of ABO matching in platelet transfusion | Q70578075 | ||
| ABO-incompatible bone marrow transplantation: the transfusion of incompatible plasma may exacerbate regimen-related toxicity | Q73287831 | ||
| P433 | issue | 3 | |
| P921 | main subject | leukemia | Q29496 |
| platelet transfusion | Q23925170 | ||
| P304 | page(s) | 631-635 | |
| P577 | publication date | 2007-09-06 | |
| P1433 | published in | Leukemia | Q6534498 |
| P1476 | title | Platelet transfusion and survival in adults with acute leukemia | |
| P478 | volume | 22 |
| Q50203571 | Blood use in patients receiving intensive chemotherapy for acute leukemia or hematopoietic stem cell transplantation: the impact of a health system-wide patient blood management program. |
| Q33435375 | Effectiveness of Pooled Platelet Transfusion in Concordant and Discordant Groups among Dengue Patients |
| Q34406572 | Human endometrial stromal stem cells differentiate into megakaryocytes with the ability to produce functional platelets |
| Q33568350 | Isoprostane and isofuran lipid mediators accumulate in stored red blood cells and influence platelet function in vitro |
| Q38604097 | New frontiers in transfusion biology: identification and significance of mediators of morbidity and mortality in stored red blood cells |
| Q47573759 | Pathogen reduction treatment alters the immunomodulatory capacity of buffy coat-derived platelet concentrates |
| Q35182623 | Platelet Activation Following Exposure to Anti-ABO Antibodies-An In Vitro Study |
| Q90373833 | Platelet Transfusion Practice and Related Outcomes in Pediatric Extracorporeal Membrane Oxygenation |
| Q40201595 | Platelet concentrates modulate myeloid dendritic cell immune responses. |
| Q37049262 | Platelet transfusion - the art and science of compromise |
| Q38362628 | Platelet transfusion - the new immunology of an old therapy |
| Q34708937 | Platelet transfusions: Impact on hemostasis, thrombosis, inflammation and clinical outcomes |
| Q84760512 | Platelets--to transfuse or not to transfuse |
| Q36973332 | Prognostic effect of blood transfusion in children with acute lymphoblastic leukemia |
| Q33436425 | Rationale and design of platelet transfusions in haematopoietic stem cell transplantation: the PATH pilot study |
| Q33400714 | The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypoproliferative thrombocytopenia |
| Q33937074 | The platelet as an immune cell-CD40 ligand and transfusion immunomodulation |
| Q36428284 | Transfusion immunomodulation--the case for leukoreduced and (perhaps) washed transfusions |
Search more.